Chandra Vargeese - 22 Jul 2024 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Signature
/s/ Chandra Vargeese
Issuer symbol
WVE
Transactions as of
22 Jul 2024
Net transactions value
+$169,161
Form type
4
Filing time
24 Jul 2024, 17:54:47 UTC
Previous filing
07 Feb 2024
Next filing
24 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Options Exercise $169,161 +68,210 +58% $2.48 185,061 22 Jul 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Options Exercise $0 -68,210 -48% $0.000000 75,332 22 Jul 2024 Ordinary Shares 68,210 $2.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,559 ordinary shares acquired on July 14, 2023, 4,135 ordinary shares acquired on January 14, 2024, and 3,533 ordinary shares acquired on July 14, 2024, under the issuer's 2019 Employee Share Purchase Plan.
F2 The share options that were exercised via cash purchase in this reportable transaction were fully vested.

Remarks:

Chief Technology Officer, Head of Platform Discovery Sciences